101 related articles for article (PubMed ID: 674933)
1. [Idiopathic hyperlipemia in the pathogenesis of functional disorders of the internal ear].
Legros M; Longuebray A; Pansier P
Rev Laryngol Otol Rhinol (Bord); 1978; 99(1-2):73-89. PubMed ID: 674933
[No Abstract] [Full Text] [Related]
2. [Is it possible to modify labyrinthine circulation?].
Martin H; Martin C; Oudot J
J Fr Otorhinolaryngol Audiophonol Chir Maxillofac; 1978 May; 27(5):331-9. PubMed ID: 149834
[No Abstract] [Full Text] [Related]
3. Cochleovestibular disorders and hyperlipidemia. A controlled trial with fenofibrate.
Torossian F; Laredo C
Monogr Atheroscler; 1986; 14():222-9. PubMed ID: 3526130
[No Abstract] [Full Text] [Related]
4. [Changes in the internal ear during the course of atrophic liver cirrhosis].
De Amicis E
Epatologia; 1970; 16(3):255-7. PubMed ID: 5525737
[No Abstract] [Full Text] [Related]
5. Inner ear dysfunction of uncertain origin: a multidisciplinary approach could give something more.
Pirodda A; Brandolini C; Ferri GG; Modugno GC; Esposti DD; Borghi C
Med Hypotheses; 2009 Feb; 72(2):188-9. PubMed ID: 19027243
[TBL] [Abstract][Full Text] [Related]
6. [Relationship between cardiovascular diseases and hyperlipemia. Benefits of hypolipemic therapy].
Daubresse JC; Luyckx A
Brux Med; 1977 Nov; 57(11):491-7. PubMed ID: 336160
[No Abstract] [Full Text] [Related]
7. [Diabetes and diseases of the internal ear].
Thibert R; Tarantino L; Piche J
J Otolaryngol; 1976 Apr; 6(2):173-9. PubMed ID: 1025318
[TBL] [Abstract][Full Text] [Related]
8. Hyperlipoproteinemia and inner ear disease.
Spencer JT
W V Med J; 1974 Sep; 70(9):215-21. PubMed ID: 4527831
[No Abstract] [Full Text] [Related]
9. [The nature and treatment of idiopathic spontaneous illnesses in our specialty].
Hasegawa T
Monatsschr Ohrenheilkd Laryngorhinol; 1966 Apr; 100(4):141-3. PubMed ID: 16114377
[No Abstract] [Full Text] [Related]
10. [Total sequestration of the labyrinth].
Ovchinnikov IuM; Dobrotin VE; Dolgikh VT; Morozova SV; Rabkin IE
Vestn Otorinolaringol; 1991; (4):35-9. PubMed ID: 1957435
[TBL] [Abstract][Full Text] [Related]
11. Is there a role for atrial peptides in the labyrinthine "disease"?
Borghi C; Modugno GC; Brandolini C; Pirodda A
Med Hypotheses; 2006; 66(6):1188-90. PubMed ID: 16431035
[TBL] [Abstract][Full Text] [Related]
12. The evaluation and management of dyslipidemia in HIV-infected patients.
Fichtenbaum CJ
AIDS Clin Care; 2001 Dec; 13(12):113-7, 120. PubMed ID: 11769116
[No Abstract] [Full Text] [Related]
13. [Management of hyperlipemia. When to administer agents that regulate lipid disorders?].
Cybulska B
Kardiol Pol; 1991; 35(8):107-15. PubMed ID: 1942755
[No Abstract] [Full Text] [Related]
14. [Acute cochleovestibular dysfunction caused by spasm of the internal auditory artery].
Mitin IuV; Krupyshev IA
Vestn Otorinolaringol; 1984; (5):65-6. PubMed ID: 6333752
[No Abstract] [Full Text] [Related]
15. Vascular pathology in the human inner ear.
Johnsson LG
Adv Otorhinolaryngol; 1973; 20():197-220. PubMed ID: 4710508
[No Abstract] [Full Text] [Related]
16. [Hyperlipemia and pancreatitis].
Carrillo Penso N; Carrasquero O; Medina JA
G E N; 1981; 35(1-2):15-27. PubMed ID: 6816659
[No Abstract] [Full Text] [Related]
17. Hyperlipoproteinemias in the etiology of inner ear disease.
Spencer JT
Laryngoscope; 1973 May; 83(5):639-78. PubMed ID: 4702467
[No Abstract] [Full Text] [Related]
18. [Causal therapy for diseases of the inner ear? (author's transl)].
von Ilberg C
HNO; 1976 Dec; 24(12):427-30. PubMed ID: 1002575
[TBL] [Abstract][Full Text] [Related]
19. [Current pharmacological agents. 7. Therapeutic agents used for the treatment of hyperlipemia and hyperuricemia (gout)].
Ando Y
Kango Gijutsu; 1986 Jul; 32(9):1176-7. PubMed ID: 3637394
[No Abstract] [Full Text] [Related]
20. [Severe disorders of the internal ear function after surgery in otosclerosis].
Nikitina VF; Zadorova TD
Vestn Otorinolaringol; 1976; (2):47-52. PubMed ID: 1274079
[No Abstract] [Full Text] [Related]
[Next] [New Search]
